In 2010, fingolimod became the latest MS drug treatment available. Before this FDA Approved MS Drug came to be, all the MS drugs used for slowing the progression of MS had to be given via injection. Fingolimod is taken orally once a day and has proved beneficial in slowing the progression of MS in patients. Preventing relapses from occurring is another use for fingolimod.

Fingolimod is able to reduce the severity of MS symptoms, as well as the frequency at which they occur. It is the first oral drug able to compete with the current injectable therapies supplied to people with Multiple Sclerosis. The severity of MS is reduced by fingolimod as this drug blocks the blood cells in lymph nodes. As these cells are blocked, they are no longer able to make their way to the spinal cord and brain.

This MS drug has provided…